Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 257 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2919 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2021-08-27 | 2021-10-07 | 144733 |
| CEFAZOLIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2022-06-03 | 2022-07-01 | 161934 |
| CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2023-04-27 | 2023-08-04 | 190779 |
| CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2023-06-20 | 2023-07-06 | 195853 |
| CEFOXITIN FOR INJECTION | 2G | POWDER FOR SOLUTION | Resolved | 2017-03-17 | 2017-09-05 | 3140 |
| CEFOXITIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2017-08-01 | 2018-01-03 | 17868 |
| CEFOXITIN FOR INJECTION | 10G | POWDER FOR SOLUTION | Resolved | 2019-06-13 | 2020-05-14 | 86614 |
| CEFOXITIN FOR INJECTION | 2G | POWDER FOR SOLUTION | Resolved | 2019-06-18 | 2019-07-15 | 86969 |
| CEFOXITIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2019-06-27 | 2020-02-07 | 87662 |
| CEFOXITIN FOR INJECTION | 2G | POWDER FOR SOLUTION | Resolved | 2019-08-22 | 2020-02-07 | 92177 |
| CEFOXITIN FOR INJECTION | 2G | POWDER FOR SOLUTION | Resolved | 2021-09-30 | 2021-10-07 | 146440 |
| CEFOXITIN FOR INJECTION | 2G | POWDER FOR SOLUTION | Resolved | 2024-06-07 | 2025-04-08 | 229942 |
| CEFOXITIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2025-04-02 | 2025-04-08 | 253960 |
| CEFOXITIN FOR INJECTION | 2G | POWDER FOR SOLUTION | Actual shortage | 2025-11-06 | 2025-12-03 | 271220 |
| CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2019-06-18 | 2019-07-15 | 86972 |
| CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2021-01-07 | 2021-02-12 | 131093 |
| CINQAIR | 10MG | SOLUTION | Resolved | 2020-05-08 | 2020-09-03 | 114421 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2019-06-27 | 2019-08-29 | 87665 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2019-11-07 | 2020-05-29 | 98188 |
| CISPLATIN INJECTION | 1.0MG | SOLUTION | Resolved | 2021-01-15 | 2021-05-06 | 131691 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |